beta-n-methylamino-l-alanine has been researched along with Cognition Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brittebo, EB; Ersson, L; Ilag, LL; Jiang, L; Karlsson, O; Malmström, T | 1 |
Brittebo, EB; Karlsson, O; Roman, E | 1 |
2 other study(ies) available for beta-n-methylamino-l-alanine and Cognition Disorders
Article | Year |
---|---|
Environmental neurotoxin interaction with proteins: Dose-dependent increase of free and protein-associated BMAA (β-N-methylamino-L-alanine) in neonatal rat brain.
Topics: Amino Acids, Diamino; Animals; Animals, Newborn; Blood-Brain Barrier; Chromatography, Liquid; Cognition Disorders; Cyanobacteria Toxins; Hippocampus; Liver; Male; Mass Spectrometry; Proteins; Rats; Rats, Wistar | 2015 |
Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine.
Topics: Aging; Amino Acids, Diamino; Animals; Animals, Newborn; Behavior, Animal; Cognition Disorders; Corticosterone; Cyanobacteria Toxins; Excitatory Amino Acid Agonists; Female; Pregnancy; Rats; Rats, Wistar | 2009 |